メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
九州大学 Pure ポータルサイト ホーム
English
日本語
ホーム
プロファイル
研究部門
プロジェクト
研究成果
データセット
活動
プレス/メディア
受賞
専門知識、名前、または所属機関で検索
乳腺外科(2)
病院
九州大学病院
概要
フィンガープリント
ネットワーク
プロファイル
(1)
研究成果
(65)
フィンガープリント
乳腺外科(2)が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Abscess
5%
Acoustic Radiation
6%
Adjuvant Chemoradiotherapy
7%
Adult
9%
Age
7%
Ascites
5%
Association
5%
Axillary Lymph Node
9%
Bile
6%
BRCA1
7%
Breast Cancer
52%
Case Report
10%
Chemoradiotherapy
16%
Cholestasis
8%
Chylous Ascites
7%
Colorectal Carcinoma
6%
Combination Therapy
14%
Computed Tomography
7%
Computer Assisted Tomography
9%
Des-Gamma Carboxyprothrombin
7%
Diagnosis
7%
Distant Metastasis Free Survival
5%
Docetaxel
7%
Donor
53%
Epidermal Growth Factor Receptor
5%
Epidermal Growth Factor Receptor 2
9%
Esophageal Cancer
11%
Esophagectomy
5%
Estrogen Receptor
12%
Fatty Liver
5%
Female
8%
Gamma Urogastrone
9%
Gastrectomy
8%
Hepatectomy
8%
Hepatic Vein
6%
Hepatocellular Carcinoma
13%
Hormone Receptor
9%
Hormone Sensitivity
5%
Hormone Therapy
19%
Host
7%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
9%
Hyperbaric Medicine
12%
Immunocompetent Cell
6%
Immunohistochemistry
5%
Incidence
5%
Inpatient
13%
Jaw
7%
Lesion
8%
Ligand
14%
Liver
49%
Liver Transplantation
39%
Lung Cancer
6%
Lung Metastasis
6%
Male
6%
Malignant Neoplasm
5%
Malignant Transformation
5%
Neoadjuvant Chemotherapy
7%
Neoplasm
21%
Overall Survival
5%
Oxygen Therapy
6%
Partial Hepatectomy
13%
Patient
100%
Phenotype
7%
Postoperative Complication
7%
Primary Tumor
14%
Progesterone Receptor
6%
Prognosis
25%
Programmed Cell Death
7%
Protein Binding
5%
Protein Expression
6%
Recurrent Disease
13%
Renal Failure
7%
Retroperitoneal Lymph Node Dissection
8%
Sacrococcygeal Teratoma
7%
Serum
7%
Skeletal Muscle
7%
Squamous Cell Carcinoma
7%
Stomach Cancer
5%
Surgeon
7%
Surgery
31%
Survival
10%
Survival Rate
6%
Synapsin II
5%
Telesurgery
7%
Therapeutic Procedure
15%
Thoracic Wall
7%
Tissues
18%
Touch
15%
Transcription Factor GATA 3
5%
Trastuzumab
14%
Trastuzumab Deruxtecan
7%
Tumor Cell
5%
Visceral Metastasis
7%
Woman
7%
Biochemistry, Genetics and Molecular Biology
Aneuploidy
10%
Association
7%
Binding Protein
14%
BRCA1
7%
Cadherin
7%
Cell Proliferation
7%
Contrast
8%
Disease Free Survival
5%
DNA
6%
Epidermal Growth Factor Receptor
7%
Estrogen Receptor
13%
Estrogen Receptor
7%
FOXA1
18%
GATA3
5%
Gene Dosage
5%
Hormone Receptor
7%
Menstrual Cycle
5%
Messenger RNA
5%
Microsatellite Instability
7%
Midkine
7%
Nested Gene
14%
Overall Survival
5%
P53
7%
Phenotype
9%
Phosphatase
5%
Protein Expression
5%
Recurrence Free Survival
5%
Robotics
7%
Sample
6%
Synapsin I
7%
Time
8%
Vimentin
13%
Vitamin Blood Level
7%
Vitamin D
7%
Voice
7%
Wild Type
5%
Pharmacology, Toxicology and Pharmaceutical Science
Anaphylaxis
5%
Binding Protein
5%
Breast Cancer
20%
Chemotherapy
7%
Chylous Ascites
7%
Colorectal Carcinoma
7%
Decarboxyprothrombin
7%
Docetaxel
7%
Epidermal Growth Factor Receptor 2
6%
Gamma Urogastrone
6%
Ligand
14%
Liver Cell Carcinoma
6%
Lung Metastasis
6%
Minimal Residual Disease
7%
Neoplasm
6%
Primary Tumor
8%
Prognosis
15%
Protein P53
7%
Recurrent Disease
10%
Survival
5%
Synapsin II
5%
Trastuzumab
7%
Tumor Growth
7%
Uvomorulin
7%
Vimentin
6%
Vitamin D
7%